Drug companies give financial support, sometimes without public knowledge, to individuals and groups that are key players in the research, diagnosis, and treatment of ADHD. The parent advocacy group Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), for example, which was instrumental in helping get ADD (as it was then called) designated as a handicapping condition under federal disability laws in the 1990s, was secretly taking money from pharmaceutical companies for years before disclosing its financial connections after a 1995 PBS broadcast revealed its underhanded dealings with drug companies.[i] It now regularly reports the amount it receives each year from Big Pharma.
Read more at Alternet
Leave a Reply